Vulvo‐vaginal rejuvenation: Fact or fiction? Fractional carbon dioxide laser for genitourinary syndrome of menopause

Harris, Victoria; Dickison, Philippa; Lim, Adrian; Fischer, Gayle

doi:10.1111/ajd.12765

Cited by 4 publications

(6 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…reported that 85% of their patients who previously abstained from sex resumed sexual activity 12 weeks post‐treatment. QoL improved significantly in three studies . Urinary incontinence scores also improved significantly, and results were maintained for at least 3 months after treatment …”

Section: Discussionmentioning

confidence: 84%

“…QoL improved significantly in three studies. 50,63,74 Urinary incontinence scores also improved significantly, 47,59,65,71,75 and results were maintained for at least 3 months after treatment. 47 Adverse events Thirteen studies reported adverse events.…”

Section: Physician Assessmentsmentioning

confidence: 84%

“…All reported an improvement compared to baseline. Sexual function was reported to improve in thirteen studies . Improvement increased in proportion to the number of treatments and results lasted 6 months following the first treatment .…”

Section: Discussionmentioning

confidence: 99%

“…Sexual function was reported to improve in thirteen studies. 39,45,50,59,[64][65][66][67][68]71,72,74,75 Improvement increased in proportion to the number of treatments 75 and results lasted 6 months following the first treatment. 68 Improvement in vestibulodynia increased with treatment number and was maintained for at least 4 months.…”

Section: Physician Assessmentsmentioning

confidence: 99%

“…Five were related to probe insertion or movement. 44,49,52,63,72 Other adverse effects included vaginal discharge, 68,74,75 urinary tract infection, 66,75 dysuria, 59,71 yeast infection, 59 pelvic pain, 64 recurrence of genital herpes, 75 burning sensation, 59,66,70 itching 59,66 bruising, 66 swelling, 59,66 numbness, 66 purpura, 66 mild irritation 65,67,70 Recommendations/long-term follow-up data Athanasiou et al 67 suggest that up to 4 or 5 sessions of CO 2 laser therapy may contribute to complete regression of dyspareunia and dryness and help re-establish normal sexual function. Sokol et al 77 found statistically significant improvement in all study parameters up to 1 year, excluding dysuria.…”

Section: Physician Assessmentsmentioning

confidence: 99%

See 4 more Smart Citations

Review of non‐invasive vulvovaginal rejuvenation

Photiou

Lin

Dubin

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

Vulvovaginal atrophy (VVA) or genitourinary syndrome of menopause (GSM) may affect up to 90% of menopausal women. Features include vulvovaginal atrophy, vulvovaginal laxity, vulvovaginal dryness and irritation, dyspareunia, anorgasmia and urinary symptoms. The vulva, vagina and bladder are oestrogen‐responsive tissues, but oestrogen replacement therapy is not possible in women who have hormone‐responsive cancers or normal oestrogen levels. Therefore, there is a role for alternative treatments. To date, three non‐surgical energy‐based therapies have been proposed: fractional microablative CO2 laser, erbium:YAG laser and temperature‐controlled radiofrequency (RF). Our objective was to assess the available evidence for the safety and efficacy of erbium:YAG laser, microablative fractional CO2 laser and RF in the treatment of VVA/GSM. The authors reviewed the current published literature evaluating these therapies. All three therapies appear safe; however, all the studies were uncontrolled and used different protocols and outcome measurements. Therefore, comparison of treatments is difficult. It appears that there is more evidence in favour of the CO2 laser than the erbium:YAG laser. Both lasers have more evidence than RF. In conclusion, microablative CO2 laser, erbium:YAG laser and RF may be offered to patients suffering from VVA/GSM as an alternative or adjunct to conventional therapies. Further well‐conducted controlled studies are needed.

show abstract

Section: Discussionmentioning

confidence: 84%

Section: Physician Assessmentsmentioning

confidence: 84%

Section: Discussionmentioning

confidence: 99%

Section: Physician Assessmentsmentioning

confidence: 99%

Section: Physician Assessmentsmentioning

confidence: 99%

See 3 more Smart Citations

Review of non‐invasive vulvovaginal rejuvenation

Photiou

Lin

Dubin

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Female Cosmetic Genital Reconstruction: a Review of Current Trends, Treatments, and Techniques

Gonzales-Alabastro

Eilber

Anger

et al. 2019

Curr Sex Health Rep

View full text Add to dashboard Cite

Involutive changes in the vulvovaginal area

Суркичин

Круглова

Apolikhina

et al. 2021

Russian Journal of Physiotherapy, Balneology and Rehabilitation

View full text Add to dashboard Cite

Involutional changes in the vulvovaginal area involve a series of transformations leading to vulvovaginal atrophy (VVA) during menopause. Signs and symptoms most often observed in this syndrome: vaginal dryness (54.4100%), dyspareunia (17.677.6%), burning (2.056.9%), itching (7.856.6%) and dysuria (5.936.1%). Other complaints include deformity of the vulva, irritation, and recurrent bacterial infections of the urinary tract or vagina, and yeast infection. Vaginal dryness, dyspareunia and irritation are the symptoms that most affect a woman's quality of life. The article analyzes modern ideas about the genitourinary syndrome of menopause. The questions of the mechanisms of occurrence are considered, a description of the clinical picture is given. The issues of treatment of atrophy of the vulvovaginal region are discussed in detail, in particular, special attention is paid to physiotherapeutic methods of treatment.

show abstract

Vulvo‐vaginal rejuvenation: Fact or fiction? Fractional carbon dioxide laser for genitourinary syndrome of menopause

Cited by 4 publications

References 6 publications

Review of non‐invasive vulvovaginal rejuvenation

Review of non‐invasive vulvovaginal rejuvenation

Female Cosmetic Genital Reconstruction: a Review of Current Trends, Treatments, and Techniques

Involutive changes in the vulvovaginal area

Contact Info

Product

Resources

About